Akebia Therapeutics (AKBA) Operating Leases (2019 - 2026)
Akebia Therapeutics (AKBA) recorded Operating Leases of $4.4 million in Q2 2026, up 555.7% from $671,000 a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2024, Akebia Therapeutics reported Operating Leases of $3.55 million, down 60.4% from FY2023.
- Annual Operating Leases has declined for three straight years, with a five-year compound annual growth rate of -33.6% (FY2019 to FY2024).
- Across earlier years, Operating Leases came in at $8.95 million in FY2023 (-69.1%), $28.96 million in FY2022 (-14.1%), $33.7 million in FY2021 (+36.9%) and $24.62 million in FY2020 (-10.6%).
- The Q2 2026 figure is the highest quarterly Operating Leases since Q3 2024.
- On a year-over-year basis, Operating Leases rose in 1 of the last five quarters, with growth averaging 56.4%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 555.7% in Q2 2026, against a decline of 89.3% in Q2 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Jun 30, 2025 | 671,000.00 |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 11.48 Mn |
| Mar 31, 2023 | 27.42 Mn |
| Dec 31, 2022 | 28.96 Mn |
| Sep 30, 2022 | 30.68 Mn |
| Jun 30, 2022 | 31.73 Mn |
| Mar 31, 2022 | 32.58 Mn |
| Dec 31, 2021 | 33.70 Mn |
| Sep 30, 2021 | 20.26 Mn |
| Jun 30, 2021 | 21.74 Mn |
| Mar 31, 2021 | 23.19 Mn |
| Dec 31, 2020 | 24.62 Mn |
API Access
Akebia Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();